Repeated Pre-treatment With Antihistamines Causes Transcriptional Up-regulations of Histamine H1 Receptor and Interleukin-4 Genes in Toluene-2,4-diisocyanate–Sensitized Rats

Abstract Antihistamines are effective for treatment of seasonal nasal allergy. Recently, prophylactic treatment with antihistamines in patients with pollinosis was reported to be more effective when started before the pollen season. The administration with antihistamines from 2 to 6 weeks before onset of the pollen season is recommended for management of allergic rhinitis in Japan. To determine the reason for the effectiveness of prophylactic treatment with antihistamines, the effects of repeated pre-treatment with antihistamines before provocation with toluene 2,4-diisocyanate (TDI) on their nasal allergy–like behavior and up-regulations of histamine H1 receptors (H1R) and interleukin (IL)-4 mRNAs in their nasal mucosa were examined. Provocation with TDI induced sneezing and up-regulations of H1R and IL-4 mRNAs in the nasal mucosa of TDI-sensitized rats. Repeated pre-treatments with antihistamines including epinastine, olopatadine, or d-chlorpheniramine for 1 to 5 weeks before provocation with TDI suppressed TDI-induced sneezing and the up-regulations of H1R and IL-4 mRNAs in the nasal mucosa more than their administrations once or for 3 days before TDI provocation. Our data indicate that repeated pre-treatment with antihistamines before provocation with TDI is more effective than their single treatment in reducing nasal allergy–like behavior by causing additional suppression of up-regulations of H1R and IL-4 mRNAs in the nasal mucosa.

[1]  N. Takeda,et al.  Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[2]  B. Klapp,et al.  Transcriptional up‐regulation of histamine receptor‐1 in epithelial, mucus and inflammatory cells in perennial allergic rhinitis , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  Noriaki Takeda,et al.  Effect of Glucocorticoid on Upregulation of Histamine H1 Receptor mRNA in Nasal Mucosa of Rats Sensitized by Exposure to Toluene Diisocyanate , 2004, Acta oto-laryngologica.

[4]  P. Kuna,et al.  Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation , 2004, Allergy.

[5]  N. Takeda,et al.  Up-regulation of histamine H1 receptors in an allergic rat nasal mucosa model , 2004, Inflammation Research.

[6]  M. Triggiani,et al.  The histamine-cytokine network in allergic inflammation. , 2003, The Journal of allergy and clinical immunology.

[7]  P. Igaz,et al.  Bidirectional communication between histamine and cytokines , 2001, Inflammation Research.

[8]  K. Austen,et al.  T Helper Cell Type 2 Cytokines Coordinately Regulate Immunoglobulin E–Dependent Cysteinyl Leukotriene Production by Human Cord Blood–Derived Mast Cells , 2001, The Journal of experimental medicine.

[9]  K. Austen,et al.  T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. , 2001 .

[10]  T. Shimosawa,et al.  Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa. , 2001, The Journal of allergy and clinical immunology.

[11]  M. Manns,et al.  IL-4 enhances proliferation and mediator release in mature human mast cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Galli,et al.  IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. , 1999, Journal of immunology.

[13]  Terada,et al.  Diesel exhaust particulates upregulate histamine receptor mRNA and increase histamine‐induced IL‐8 and GM‐CSF production in nasal epithelial cells and endothelial cells , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  W. Paul,et al.  The IL-4 receptor: signaling mechanisms and biologic functions. , 1999, Annual review of immunology.

[15]  Bachert.  Histamine – a major role in allergy? , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  A Bast,et al.  Histamine affects interleukin-4, interleukin-5, and interferon-gamma production by human T cell clones from the airways and blood. , 1998, American journal of respiratory cell and molecular biology.

[17]  H. Bayram,et al.  Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. , 1998, The Journal of allergy and clinical immunology.

[18]  E. Meltzer,et al.  Prevalence of allergic rhinitis in the United States , 1997 .

[19]  J. Bousquet,et al.  Different modulation by histamine of IL‐4 and interferon‐gamma (IFN‐γ) release according to the phenotype of human Th0, Th1 and Th2 clones , 1997, Clinical and experimental immunology.

[20]  D. Tudor,et al.  Can an antihistamine delay appearance of hay fever symptoms when given prior to pollen season? , 1997, Allergy.

[21]  Y. Sasaguri,et al.  Interleukin‐4 stimulates rheumatoid synovial fibroblasts to express matrix metalloproteinase‐1 (tissue collagenase) and histamine H1 receptor mRNA , 1996, Biochemistry and molecular biology international.

[22]  K. Takeuchi,et al.  Increased expression of histamine H1 receptor mRNA in allergic rhinitis , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  M. Joseph,et al.  Histamine induces IL‐6 production by human endothelial cells , 1994, Clinical and experimental immunology.

[24]  S. Holgate,et al.  The 1992 Cournand Lecture. Asthma: past, present and future. , 1993, The European respiratory journal.

[25]  H. Fukui,et al.  Histamine content, synthesis and degradation in nasal mucosa and lung of guinea‐pigs treated with toluene diisocyanate (TDI) , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  T. Kubo,et al.  Neuropharmacology of motion sickness and emesis. A review. , 1993, Acta oto-laryngologica. Supplementum.

[27]  M. Tohyama,et al.  Nasal mucosa sensitization with toluene diisocyanate (TDI) increases preprotachykinin A (PPTA) and preproCGRP mRNAs in guinea pig trigeminal ganglion neurons , 1992, Brain Research.

[28]  H. Fukui,et al.  Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs. , 1992, Acta oto-laryngologica.

[29]  M. White,et al.  The role of histamine in allergic diseases. , 1990, The Journal of allergy and clinical immunology.

[30]  E. Juniper,et al.  Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. , 1989, The Journal of allergy and clinical immunology.

[31]  S. Hanada,et al.  A nasal allergy model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate. , 1988, International archives of allergy and applied immunology.

[32]  L. Fabbri,et al.  Pathogenesis of late asthmatic reactions induced by exposure to isocyanates. , 1987, Bulletin europeen de physiopathologie respiratoire.

[33]  D. Wegman,et al.  Epidemiology of toluene diisocyanate (TDI)-induced respiratory disease. , 1975, Environmental health perspectives.